| 1 |
35111281 | Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study. | 2022 |
1 |
| 2 |
35242380 | The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patients. | 2022 Jan |
2 |
| 3 |
35280362 | Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer. | 2022 Feb |
2 |
| 4 |
35344507 | TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types. | 2022 Mar 27 |
1 |
| 5 |
35368662 | TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients. | 2022 |
3 |
| 6 |
35491653 | Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer. | 2022 May 2 |
3 |
| 7 |
35601155 | Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | 2022 |
1 |
| 8 |
33391418 | LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma. | 2021 |
2 |
| 9 |
33454519 | The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients. | 2021 Mar |
1 |
| 10 |
33879103 | RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer. | 2021 Apr 20 |
2 |
| 11 |
33987249 | Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer. | 2021 Apr |
1 |
| 12 |
34098386 | Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer. | 2021 Aug |
1 |
| 13 |
34620079 | The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors. | 2021 Oct 7 |
1 |
| 14 |
34745095 | Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia. | 2021 |
2 |
| 15 |
34745455 | Multiomics analysis of tumor mutational burden across cancer types. | 2021 |
1 |
| 16 |
34917611 | TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer. | 2021 |
1 |
| 17 |
31596511 | Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma. | 2020 Apr |
1 |
| 18 |
31807880 | Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer. | 2020 Jan |
2 |
| 19 |
32218826 | Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma. | 2020 Apr |
1 |
| 20 |
32694238 | TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy. | 2020 Jul 22 |
1 |
| 21 |
32739866 | TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection. | 2020 Aug |
1 |
| 22 |
32743759 | Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma. | 2020 Nov |
2 |
| 23 |
32927274 | Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma. | 2020 Oct |
1 |
| 24 |
33072585 | A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma. | 2020 |
2 |
| 25 |
33178836 | Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma. | 2020 |
1 |
| 26 |
33219256 | Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. | 2020 Nov 20 |
1 |
| 27 |
33363171 | Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer. | 2020 |
1 |
| 28 |
33996530 | Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer. | 2020 |
1 |
| 29 |
31097096 | Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer. | 2019 Jun |
1 |
| 30 |
31164161 | Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. | 2019 Jun 4 |
1 |
| 31 |
31173964 | Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. | 2019 Jul |
2 |
| 32 |
28892622 | Gold-Loaded Nanoporous Ferric Oxide Nanocubes with Peroxidase-Mimicking Activity for Electrocatalytic and Colorimetric Detection of Autoantibody. | 2017 Oct 17 |
2 |